Pharmacokinetics of iptakalim hydrochloride of single and muti-dose and E-QT research in human subjects.
Phase of Trial: Phase I
Latest Information Update: 23 Jan 2018
Price : $35 *
At a glance
- Drugs Iptakalim (Primary)
- Indications Cardiovascular disorders
- Focus Adverse reactions; Pharmacokinetics
- 24 Jan 2050 Observational has been kept as per the record. It should be checked and update in future.
- 23 Jan 2018 New trial record